Je. Hollander et al., Risk stratification of emergency department patients with acute coronary syndromes using P-selectin, J AM COL C, 34(1), 1999, pp. 95-105
Citations number
55
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES We compared the predictive properties of P-selectin to creatine
kinase, RIB fraction(CK-MB) for detecting acute myocardial infarction (AMI)
, acute coronary syndromes (ACS) and serious cardiac events upon emergency
department (ED) arrival.
BACKGROUND Practioners detecting early diagnosis of ACS have focused on car
diac markers of myocardial injury. Plaque rupture/platelet aggregation prec
edes myocardial ischemia. Therefore, markers of platelet aggregation may de
tect ACS earlier than cardiac markers.
METHODS Consecutive patients with potential ACS presenting to an urban univ
ersity ED were identified by research assistants who screened all ED patien
ts between November 12, 1997 and January 31, 1998. Whole blood was drawn at
presentation and 1 h later and rapidly stained and fixed fur membrane P-se
lectin assay and plasma was separated fur soluble P-selectin assay. Creatin
e kinase, MB fraction values were determined using standard immunoassay tec
hniques. Clinical history and hospital course were followed daily. Outcomes
were AMI, ACS (AMI and unstable angina) and serious cardiac events. Receiv
er operator characteristic curves were derived for CK-MB, and soluble and m
embrane-bound P-selectin to determine the optimal cutoff values. Predictive
properties were calculated with 95% confidence intervals.
RESULTS A total of 263 patients were enrolled. They had a mean age of 56.5
+/- 14 years; 52% were male. There were 22 patients with AMI; 87 patients w
ith ACS and 54 patients with serious cardiac events. Creatine kinase, MB fr
action had a higher specificity for detection of AMI, ACS and serious cardi
ac events than both soluble and membrane-bound P-selectin. At the time of E
D presentation, the specificity of CK-R-IB, and soluble and membrane-bound
P-selectin for AMI was 91% versus 76% versus 71%; for ACS, 95% versus 79% v
ersus 71%, and for serious cardiac events, 91% versus 76% versus 72% (p < 0
.05). The sensitivities for AMI were 50% versus 45% versus 32%; for ACS, 26
% versus 35% versus 30%, and for serious cardiac events, 29% versus 35% ver
sus 36%.
CONCLUSIONS Although theoretically attractive, the use of soluble and membr
ane-bound P-selectin for risk stratification of chest pain patients at the
time of ED presentation does not appear to have any advantages over the use
of CK-MB. (C) 1999 by the American College of Cardiology.